Hints and tips:
Related Special Reports
...In the UK companies cannot advertise prescription medicines to the public but are allowed to promote them to healthcare professionals....
...The company predicted that the market for medical cannabis would grow rapidly in Germany and elsewhere in Europe where the drug was cleared for medical usage....
...PwC, meanwhile, has split tax between its advisory and assurance businesses in the US....
...Christoph Schweizer told the Financial Times that AI and generative AI were “a huge boost” to revenues in the past year as companies move from experimenting with the technology to “at-scale deployment”....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...in the medical technology sector....
...The FTSE 250 company, which runs 39 hospitals as well as clinics and medical centres, said it was also benefiting from a strong rebound in corporate private medical insurance as more employers take out policies...
...of the company’s account....
...The US healthcare company said it now expected diluted earnings per share to be at least $7.06, down from previous estimates of at least $7.26....
...implied, they do not warrant medical attention....
...“Because organoids can be made from human cells, they can model aspects of human biology that cannot be captured in animal testing,” said Lancaster, group leader at the UK Medical Research Council Laboratory...
...Enterprise software company SAP, meanwhile, unveiled a “company-wide transformation” in January that will include the axing of around 8,000 jobs as the company increases its focus on AI....
...associate professor at Harvard Medical School and Massachusetts General Hospital....
...In overturning his pay package, the court said Musk, who owns more than a fifth of the company, was too cosy with Tesla’s board and the value of the package was unfair to other shareholders....
...London market is a scapegoat for poor performance When a UK company’s share price goes south, simply blame the London market....
...The company said that adjusted earnings for 2024 would be about $16 a share, missing analyst forecasts of $29.10 a share, as it expects higher medical costs to be an industry wide trend that will persist...
...In recent months NHS staff and medical trade unions have voiced concerns about its suitability to run national health systems, as well as the dangers of the service relying on a single private company for...
...“Further ‘real-world’ tests of the approach are needed to understand how well it will cope with all the variability in the general population, including the presence of other conditions which can affect...
...This investigation into environmental assurance work by KPMG highlights the risks of taking such audits at face value....
...And Peltz could also provide “assurance to other investors that the board is properly engaged this time around”....
...to do serious damage to the super-profitable business model of some Big Tech company....
...Menzies has been accused of using thousands of pounds given by donors for medical bills and other unusual personal expenses, according to The Times, which added that the Conservative party had been aware...
...This was characterised by the gentrified “Banana” syndrome — “build absolutely nothing anywhere near anything”. He was in good company....
...Companies such as Blackrock Neurotech, created in 2008, and Neuralink remove a piece of skull and add sensors directly on to the brain to pick up electrical signals....
...“Today in America, the retirement message that the government and companies tell their workers is effectively: ‘You’re on your own.’”...
International Edition